Acute administration of leptin produces anxiolytic-like effects

A comparison with fluoxetine

Jing Liu, Jacob C. Garza, Jamaur Bronner, Chung Sub Kim, Wei Zhang, Xinyun Lu

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Rationale: Our previous studies in rats have shown that the adipocyte-derived hormone leptin induces antidepressant-like effects with a behavioral profile similar to selective serotonin reuptake inhibitor (SSRI) antidepressants. Acute SSRI treatment causes paradoxical anxiogenic responses, although chronic treatment has therapeutic effects on anxiety. However, the role of leptin in anxiety remains to be established. Objectives: The scope of this study was to investigate the acute effects of leptin on anxiety-related behaviors in comparison with the SSRI antidepressant fluoxetine. Materials and methods: Adult male C57BL/6J mice received intraperitoneal injection of leptin or fluoxetine. Thirty minutes after injection, mice were subjected to the tail suspension test (TST) and forced swim test (FST) for evaluating antidepressant activity. Anxiety-like behavior was assessed in the elevated plus maze (EPM), social interaction, and open field tests 30 min following drug treatment. Results: While leptin and fluoxetine showed similar antidepressant-like behavioral effects in the TST and FST, they differed in the behavioral assays for anxiety. Open arm exploration in the EPM was increased by leptin but decreased by fluoxetine. Analysis of social interaction revealed that distinct social behavioral components were modulated by leptin and fluoxetine. The total time of active social behaviors was increased by leptin but reduced by fluoxetine. In addition, self-grooming, a non-social behavior, was suppressed by leptin treatment. Neither leptin nor fluoxetine produced significant effects in the open field test. Conclusions: In contrast to anxiogenic-like effects induced by acute fluoxetine, leptin elicits anxiolytic-like effects after acute administration. These results suggest that leptin has both antidepressant-like and anxiolytic-like properties.

Original languageEnglish (US)
Pages (from-to)535-545
Number of pages11
JournalPsychopharmacology
Volume207
Issue number4
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Fluoxetine
Anti-Anxiety Agents
Leptin
Antidepressive Agents
Anxiety
Serotonin Uptake Inhibitors
Hindlimb Suspension
Interpersonal Relations
Grooming
Social Behavior
Therapeutic Uses
Therapeutics
Intraperitoneal Injections
Inbred C57BL Mouse
Adipocytes
Hormones

Keywords

  • Anxiety
  • Depression
  • Elevated plus maze
  • Fluoxetine
  • Forced swim
  • Leptin
  • Social interaction
  • Tail suspension

ASJC Scopus subject areas

  • Pharmacology

Cite this

Acute administration of leptin produces anxiolytic-like effects : A comparison with fluoxetine. / Liu, Jing; Garza, Jacob C.; Bronner, Jamaur; Kim, Chung Sub; Zhang, Wei; Lu, Xinyun.

In: Psychopharmacology, Vol. 207, No. 4, 01.01.2010, p. 535-545.

Research output: Contribution to journalArticle

Liu, Jing ; Garza, Jacob C. ; Bronner, Jamaur ; Kim, Chung Sub ; Zhang, Wei ; Lu, Xinyun. / Acute administration of leptin produces anxiolytic-like effects : A comparison with fluoxetine. In: Psychopharmacology. 2010 ; Vol. 207, No. 4. pp. 535-545.
@article{ab1c15e4330d4450bd36c8721aee3838,
title = "Acute administration of leptin produces anxiolytic-like effects: A comparison with fluoxetine",
abstract = "Rationale: Our previous studies in rats have shown that the adipocyte-derived hormone leptin induces antidepressant-like effects with a behavioral profile similar to selective serotonin reuptake inhibitor (SSRI) antidepressants. Acute SSRI treatment causes paradoxical anxiogenic responses, although chronic treatment has therapeutic effects on anxiety. However, the role of leptin in anxiety remains to be established. Objectives: The scope of this study was to investigate the acute effects of leptin on anxiety-related behaviors in comparison with the SSRI antidepressant fluoxetine. Materials and methods: Adult male C57BL/6J mice received intraperitoneal injection of leptin or fluoxetine. Thirty minutes after injection, mice were subjected to the tail suspension test (TST) and forced swim test (FST) for evaluating antidepressant activity. Anxiety-like behavior was assessed in the elevated plus maze (EPM), social interaction, and open field tests 30 min following drug treatment. Results: While leptin and fluoxetine showed similar antidepressant-like behavioral effects in the TST and FST, they differed in the behavioral assays for anxiety. Open arm exploration in the EPM was increased by leptin but decreased by fluoxetine. Analysis of social interaction revealed that distinct social behavioral components were modulated by leptin and fluoxetine. The total time of active social behaviors was increased by leptin but reduced by fluoxetine. In addition, self-grooming, a non-social behavior, was suppressed by leptin treatment. Neither leptin nor fluoxetine produced significant effects in the open field test. Conclusions: In contrast to anxiogenic-like effects induced by acute fluoxetine, leptin elicits anxiolytic-like effects after acute administration. These results suggest that leptin has both antidepressant-like and anxiolytic-like properties.",
keywords = "Anxiety, Depression, Elevated plus maze, Fluoxetine, Forced swim, Leptin, Social interaction, Tail suspension",
author = "Jing Liu and Garza, {Jacob C.} and Jamaur Bronner and Kim, {Chung Sub} and Wei Zhang and Xinyun Lu",
year = "2010",
month = "1",
day = "1",
doi = "10.1007/s00213-009-1684-3",
language = "English (US)",
volume = "207",
pages = "535--545",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Acute administration of leptin produces anxiolytic-like effects

T2 - A comparison with fluoxetine

AU - Liu, Jing

AU - Garza, Jacob C.

AU - Bronner, Jamaur

AU - Kim, Chung Sub

AU - Zhang, Wei

AU - Lu, Xinyun

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Rationale: Our previous studies in rats have shown that the adipocyte-derived hormone leptin induces antidepressant-like effects with a behavioral profile similar to selective serotonin reuptake inhibitor (SSRI) antidepressants. Acute SSRI treatment causes paradoxical anxiogenic responses, although chronic treatment has therapeutic effects on anxiety. However, the role of leptin in anxiety remains to be established. Objectives: The scope of this study was to investigate the acute effects of leptin on anxiety-related behaviors in comparison with the SSRI antidepressant fluoxetine. Materials and methods: Adult male C57BL/6J mice received intraperitoneal injection of leptin or fluoxetine. Thirty minutes after injection, mice were subjected to the tail suspension test (TST) and forced swim test (FST) for evaluating antidepressant activity. Anxiety-like behavior was assessed in the elevated plus maze (EPM), social interaction, and open field tests 30 min following drug treatment. Results: While leptin and fluoxetine showed similar antidepressant-like behavioral effects in the TST and FST, they differed in the behavioral assays for anxiety. Open arm exploration in the EPM was increased by leptin but decreased by fluoxetine. Analysis of social interaction revealed that distinct social behavioral components were modulated by leptin and fluoxetine. The total time of active social behaviors was increased by leptin but reduced by fluoxetine. In addition, self-grooming, a non-social behavior, was suppressed by leptin treatment. Neither leptin nor fluoxetine produced significant effects in the open field test. Conclusions: In contrast to anxiogenic-like effects induced by acute fluoxetine, leptin elicits anxiolytic-like effects after acute administration. These results suggest that leptin has both antidepressant-like and anxiolytic-like properties.

AB - Rationale: Our previous studies in rats have shown that the adipocyte-derived hormone leptin induces antidepressant-like effects with a behavioral profile similar to selective serotonin reuptake inhibitor (SSRI) antidepressants. Acute SSRI treatment causes paradoxical anxiogenic responses, although chronic treatment has therapeutic effects on anxiety. However, the role of leptin in anxiety remains to be established. Objectives: The scope of this study was to investigate the acute effects of leptin on anxiety-related behaviors in comparison with the SSRI antidepressant fluoxetine. Materials and methods: Adult male C57BL/6J mice received intraperitoneal injection of leptin or fluoxetine. Thirty minutes after injection, mice were subjected to the tail suspension test (TST) and forced swim test (FST) for evaluating antidepressant activity. Anxiety-like behavior was assessed in the elevated plus maze (EPM), social interaction, and open field tests 30 min following drug treatment. Results: While leptin and fluoxetine showed similar antidepressant-like behavioral effects in the TST and FST, they differed in the behavioral assays for anxiety. Open arm exploration in the EPM was increased by leptin but decreased by fluoxetine. Analysis of social interaction revealed that distinct social behavioral components were modulated by leptin and fluoxetine. The total time of active social behaviors was increased by leptin but reduced by fluoxetine. In addition, self-grooming, a non-social behavior, was suppressed by leptin treatment. Neither leptin nor fluoxetine produced significant effects in the open field test. Conclusions: In contrast to anxiogenic-like effects induced by acute fluoxetine, leptin elicits anxiolytic-like effects after acute administration. These results suggest that leptin has both antidepressant-like and anxiolytic-like properties.

KW - Anxiety

KW - Depression

KW - Elevated plus maze

KW - Fluoxetine

KW - Forced swim

KW - Leptin

KW - Social interaction

KW - Tail suspension

UR - http://www.scopus.com/inward/record.url?scp=72049111492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72049111492&partnerID=8YFLogxK

U2 - 10.1007/s00213-009-1684-3

DO - 10.1007/s00213-009-1684-3

M3 - Article

VL - 207

SP - 535

EP - 545

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 4

ER -